Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin.

Hartl M, Puglisi K, Nist A, Raffeiner P, Bister K.

Mol Oncol. 2020 Jan 16. doi: 10.1002/1878-0261.12636. [Epub ahead of print]

2.

PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9.

Bell CM, Raffeiner P, Hart JR, Vogt PK.

Cancers (Basel). 2019 Oct 24;11(11). pii: E1634. doi: 10.3390/cancers11111634.

3.

BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS.

Röck R, Mayrhofer JE, Torres-Quesada O, Enzler F, Raffeiner A, Raffeiner P, Feichtner A, Huber RG, Koide S, Taylor SS, Troppmair J, Stefan E.

Sci Adv. 2019 Aug 14;5(8):eaav8463. doi: 10.1126/sciadv.aav8463. eCollection 2019 Aug.

4.

Metabolomics Reveals that Dietary Xenoestrogens Alter Cellular Metabolism Induced by Palbociclib/Letrozole Combination Cancer Therapy.

Warth B, Raffeiner P, Granados A, Huan T, Fang M, Forsberg EM, Benton HP, Goetz L, Johnson CH, Siuzdak G.

Cell Chem Biol. 2018 Mar 15;25(3):291-300.e3. doi: 10.1016/j.chembiol.2017.12.010. Epub 2018 Jan 11.

5.

Calcium-dependent binding of Myc to calmodulin.

Raffeiner P, Schraffl A, Schwarz T, Röck R, Ledolter K, Hartl M, Konrat R, Stefan E, Bister K.

Oncotarget. 2017 Jan 10;8(2):3327-3343. doi: 10.18632/oncotarget.13759.

6.

Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling.

Bachmann VA, Mayrhofer JE, Ilouz R, Tschaikner P, Raffeiner P, Röck R, Courcelles M, Apelt F, Lu TW, Baillie GS, Thibault P, Aanstad P, Stelzl U, Taylor SS, Stefan E.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7786-91. doi: 10.1073/pnas.1608061113. Epub 2016 Jun 28.

7.

In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs.

Röck R, Bachmann V, Bhang HE, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E.

Sci Rep. 2015 Jun 23;5:11133. doi: 10.1038/srep11133.

8.

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential.

Raffeiner P, Röck R, Schraffl A, Hartl M, Hart JR, Janda KD, Vogt PK, Stefan E, Bister K.

Oncotarget. 2014 Oct 15;5(19):8869-78.

9.

Transcriptional control of DNA replication licensing by Myc.

Valovka T, Schönfeld M, Raffeiner P, Breuker K, Dunzendorfer-Matt T, Hartl M, Bister K.

Sci Rep. 2013 Dec 6;3:3444. doi: 10.1038/srep03444.

Supplemental Content

Loading ...
Support Center